Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®
Acquiring the Canadian rights toLEVULAN KERASTICK (aminolevulinic acid hydrochloride) further expands the Sun Pharma Canada dermatology portfolio and reinforces the company's commitment to patient care. Sun Pharma, a global pharmaceutical company with a growing portfolio of Innovative Medicines, today announced it acquired, at no cost, the commercial sales rights to LEVULAN KERASTICK (aminolevulinic acid hydrochloride) […]